2014
DOI: 10.1097/smj.0000000000000051
|View full text |Cite
|
Sign up to set email alerts
|

Vitamin D Insufficiency/Deficiency Management

Abstract: Vitamin D deficiency and insufficiency are highly prevalent. Clinicians tended to prescribe a high dose of treatment for lower levels of serum vitamin D. The response is higher in high-dose treatment. Documentation regarding whether vitamin D supplements were given or the dose of supplements was given and followed up with repeat levels of vitamin D after treatment was poor.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 1 publication
0
9
0
2
Order By: Relevance
“…Our study identifies the incidence of vitamin D insufficiency in terms of serum 25(OH)D <75 nmol/L (<30 ng/mL) and deficiency <50 nmol/L (<20 ng/mL) [13, 14]. This study shows that 63.3% of the patients had vitamin D deficiency and 100% had insufficiency, while, among the controls, 50% had insufficiency and 0% had deficiency.…”
Section: Discussionmentioning
confidence: 99%
“…Our study identifies the incidence of vitamin D insufficiency in terms of serum 25(OH)D <75 nmol/L (<30 ng/mL) and deficiency <50 nmol/L (<20 ng/mL) [13, 14]. This study shows that 63.3% of the patients had vitamin D deficiency and 100% had insufficiency, while, among the controls, 50% had insufficiency and 0% had deficiency.…”
Section: Discussionmentioning
confidence: 99%
“…We demonstrate for the first time that VD biosynthesis and/or metabolism is compromised in BRCA1 mut carriers. While BRCA wt women had a normal VD status (44.1 ng/ml on average), BRCA1 mut carriers exhibited VD-insufficiency (29.4 ng/ml on average) according to the clinical definition (20-29.9 ng/ml serum calcifediol) [25], despite a lack of data on UV light exposure and diet supplementation. Ineffective conversion of skin-derived and dietary cholecalciferol into calcifediol in the liver may result from previously reported BRCA1 mutrelated liver dysfunction [36].…”
Section: Discussionmentioning
confidence: 99%
“…Although ages were comparable between BRCA1 mut carriers and BRCA wt patients (36.1 ± 1.7 versus 37.1 ± 1.4 years; p = 0.33), BRCA1 mut carriers had ~33% lower (p = 0.003) serum calcifediol concentrations than those of BRCA wt patients (29.4 ± 2.3 versus 44.1 ± 4.0 ng/ml). Serum calcifediol level of 20-29.9 ng/ml is defined as VD insufficiency [25]. While ~92% (12 of 13) of BRCA wt patients had healthy levels of VD (> 30 ng/ml serum calcifediol), 54% (6 of 11) of BRCA1 mut carriers exhibited VD insufficiency (21.7-27.7 ng/ml serum calcifediol) ( Table 2).…”
Section: Reduced Serum Vd Levels In Healthy Women With Brca1 Mutmentioning
confidence: 99%
“…Atualmente, a deficiência de vitamina D é considerada uma epidemia, e a suplementação desta vitamina tem sido cada vez mais recomendada 39 . A suplementação com micronutrientes pode ajudar a evitar o desenvolvimento de doenças, contudo sua ingestão excessiva, principalmente das vitaminas lipossolúveis, pode trazer consequências à saúde, causando diversos problemas, como danos hepáticos, descamação na pele, enxaqueca e vômito 40 .…”
Section: Riscos à Saúdeunclassified